Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$14.28 - $31.03 $1.52 Million - $3.3 Million
106,500 Added 355.0%
136,500 $4.04 Million
Q3 2023

Nov 14, 2023

SELL
$19.33 - $36.22 $226,160 - $423,774
-11,700 Reduced 28.06%
30,000 $623,000
Q2 2023

Aug 14, 2023

BUY
$24.18 - $42.46 $1.01 Million - $1.77 Million
41,700 New
41,700 $1.02 Million
Q4 2022

Feb 14, 2023

BUY
$35.49 - $56.15 $1.42 Million - $2.25 Million
40,000 New
40,000 $1.8 Million
Q1 2022

May 16, 2022

SELL
$101.89 - $150.09 $2.55 Million - $3.75 Million
-25,000 Reduced 34.15%
48,200 $5.61 Million
Q4 2021

Feb 14, 2022

BUY
$118.18 - $153.21 $2.87 Million - $3.72 Million
24,300 Added 49.69%
73,200 $11 Million
Q2 2021

Aug 16, 2021

BUY
$77.0 - $100.19 $2.23 Million - $2.9 Million
28,900 Added 144.5%
48,900 $4.76 Million
Q1 2021

May 17, 2021

SELL
$81.28 - $104.34 $105,664 - $135,642
-1,300 Reduced 6.1%
20,000 $1.77 Million
Q3 2020

Nov 16, 2020

BUY
$95.43 - $116.09 $1.2 Million - $1.46 Million
12,600 Added 144.83%
21,300 $2.42 Million
Q3 2019

Nov 14, 2019

SELL
$57.11 - $73.3 $1.75 Million - $2.24 Million
-30,600 Reduced 77.86%
8,700 $513,000
Q2 2019

Aug 14, 2019

BUY
$54.41 - $71.7 $81,615 - $107,550
1,500 Added 3.97%
39,300 $2.54 Million
Q1 2019

May 15, 2019

SELL
$32.25 - $73.56 $9.18 Million - $20.9 Million
-284,800 Reduced 88.28%
37,800 $2.4 Million
Q4 2018

Feb 14, 2019

BUY
$28.45 - $40.65 $6.45 Million - $9.21 Million
226,600 Added 236.04%
322,600 $12.2 Million
Q3 2018

Nov 14, 2018

BUY
$21.39 - $51.17 $2.05 Million - $4.91 Million
96,000 New
96,000 $4.11 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $1.97B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.